SCHEMBL1826410

SCHEMBL1826410

CC(C)(C)OC(=O)NCC(O)c1ccccc1OS(C)(=O)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.44
MALT1 Q9UDY8 1/20 0.40
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA7 P43166 1/20 0.39
CA14 Q9ULX7 1/20 0.39
DRD2 P14416 2/20 0.38
CTSS P25774 3/20 0.37
CTSK P43235 2/20 0.37
CTSL P07711 1/20 0.37
CTSB P07858 1/20 0.37
ADRB2 P07550 1/20 0.37
HTR1A P08908 1/20 0.37
EPHX2 P34913 1/20 0.37
KDM4A O75164 1/20 0.37
NQO2 P16083 1/20 0.37
ATM Q13315 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
PCSK9 Q8NBP7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1827850 0.87 SYK (0.42) SYKMALT1CA12CA1CA7
SCHEMBL4582959 0.86 DRD2 (0.49) SYKMALT1DRD2CTSSCTSK
SCHEMBL1824955 0.86 SYK (0.42) SYKMALT1CA12CA1CA7
SCHEMBL1826280 0.84 LMNA (0.41) SYKMALT1CA12CA1CA2
SCHEMBL1826401 0.84 SYK (0.41) SYKMALT1CA12CA1CA7
SCHEMBL1824624 0.81 SYK (0.51) SYKMALT1CA12CA1CA7
SCHEMBL12322222 0.80 SYK (0.54) SYKCA12CA1CA7CA14
SCHEMBL12321493 0.79 SYK (0.46) SYKMALT1CTSSCTSKCTSL
SCHEMBL2439786 0.78 ADRB2 (0.58) SYKMALT1DRD2CTSSCTSK
SCHEMBL1824911 0.78 CA12 (0.43) SYKMALT1CA12CA1CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 SYK 1520/4885MALT1 155/4885CA12 1498/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 SYK 1172/4885MALT1 477/4885CA12 670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.